These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6504706)

  • 41. Study of DNA-ellipticine interaction by capillary electrophoresis with laser-induced fluorescence detection.
    Ryvolova M; Adam V; Eckschlager T; Stiborova M; Kizek R
    Electrophoresis; 2012 Jun; 33(11):1545-9. PubMed ID: 22736355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of anti-RNA properties of normal and ellipticine functionalized alpha and beta-oligonucleotides.
    Lavignon M; Bertrand JR; Porumb H; Rayner B; Imbach JL; Paoletti C; Malvy C
    Nucleic Acids Symp Ser; 1991; (24):117-9. PubMed ID: 1668683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
    Neubort S; Liebeskind D; Mendez F; Elequin F; Hsu KC; Bases R
    Mol Pharmacol; 1982 May; 21(3):739-43. PubMed ID: 7050651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
    Sorace RA; Sheid B
    Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
    [No Abstract]   [Full Text] [Related]  

  • 45. Grossularine-1 and grossularine-2, alpha carbolines from Dendrodoa grossularia, as possible intercalative agents.
    Helbecque N; Moquin C; Bernier JL; Morel E; Guyot M; Henichart JP
    Cancer Biochem Biophys; 1987 Sep; 9(3):271-9. PubMed ID: 3435899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of bifunctional oligonucleotide intercalator conjugates as inhibitors of gene expression.
    Helene C; Thuong NT
    Nucleic Acids Symp Ser; 1991; (24):133-7. PubMed ID: 1668684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
    Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
    Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
    Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
    Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
    Traganos F; Kapuscinski J; Darzynkiewicz Z
    Cancer Res; 1991 Jul; 51(14):3682-9. PubMed ID: 2065324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells.
    Poljaková J; Frei E; Gomez JE; Aimová D; Eckschlager T; Hrabeta J; Stiborová M
    Cancer Lett; 2007 Jul; 252(2):270-9. PubMed ID: 17306925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of 9-OH-ellipticine on cell survival, macromolecular syntheses, and cell cycle progression in sensitive and resistant Chinese hamster lung cells.
    Charcosset JY; Bendirdjian JP; Lantieri MF; Jacquemin-Sablon A
    Cancer Res; 1985 Sep; 45(9):4229-36. PubMed ID: 2992775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.
    Aimová D; Svobodová L; Kotrbová V; Mrázová B; Hodek P; Hudecek J; Václavíková R; Frei E; Stiborová M
    Drug Metab Dispos; 2007 Oct; 35(10):1926-34. PubMed ID: 17656468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Covalent protein-DNA complexes at the 5' strand termini of meiosis-specific double-strand breaks in yeast.
    Keeney S; Kleckner N
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11274-8. PubMed ID: 7479978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II].
    Douc-Rasy S; Multon E; Kayser A; Riou G
    C R Seances Acad Sci III; 1983; 296(19):899-904. PubMed ID: 6311366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
    Savorani C; Manfé V; Biskup E; Gniadecki R
    Leuk Lymphoma; 2015 Mar; 56(3):739-47. PubMed ID: 24898668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
    Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy.
    Kotrbová V; Mrázová B; Moserová M; Martínek V; Hodek P; Hudeček J; Frei E; Stiborová M
    Biochem Pharmacol; 2011 Sep; 82(6):669-80. PubMed ID: 21683692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.
    Fossé P; René B; Le Bret M; Paoletti C; Saucier JM
    Nucleic Acids Res; 1991 Jun; 19(11):2861-8. PubMed ID: 1647520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regioselection Switch in Nucleophilic Addition to Isoquinolinequinones: Mechanism and Origin of the Regioselectivity in the Total Synthesis of Ellipticine.
    Castro JAM; Serikava BK; Maior CRS; Naciuk FF; Rocco SA; Ligiéro CBP; Morgon NH; Miranda PCML
    J Org Chem; 2022 Jun; 87(12):7610-7617. PubMed ID: 35171607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.